TWD 29.65
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 39.9 Million TWD | 24.48% |
2022 | 32.05 Million TWD | 2.13% |
2021 | 31.38 Million TWD | -28.24% |
2020 | 43.74 Million TWD | 30.45% |
2019 | 33.53 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 9.39 Million TWD | 17.3% |
2024 Q2 | 15 Million TWD | 59.72% |
2023 FY | 39.9 Million TWD | 24.48% |
2023 Q4 | 8.01 Million TWD | 13.04% |
2023 Q3 | 7.08 Million TWD | -56.24% |
2023 Q2 | 16.19 Million TWD | 88.16% |
2023 Q1 | 8.6 Million TWD | 9.35% |
2022 Q4 | 7.87 Million TWD | 0.0% |
2022 FY | 32.05 Million TWD | 2.13% |
2021 FY | 31.38 Million TWD | -28.24% |
2020 FY | 43.74 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 96.42% |
Level Biotechnology Inc. | 660.61 Million TWD | 93.96% |
Sagittarius Life Science Corp | 440.46 Million TWD | 90.941% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 38.354% |
TaiMed Biologics Inc. | 491.77 Million TWD | 91.886% |
GlycoNex Incorporation | 2.54 Million TWD | -1469.748% |
VBI | 55.85 Million TWD | 28.557% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 82.302% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 87.372% |
Visgeneer Inc. | 147.99 Million TWD | 73.037% |
Mycenax Biotech Inc. | 652.62 Million TWD | 93.886% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 97.637% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 78.008% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 89.759% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -75.46% |
Enimmune corporation | 43.49 Million TWD | 8.256% |
TaiRx, Inc. | 5.08 Million TWD | -685.183% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 96.098% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 84.927% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 90.695% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 63.694% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 77.903% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -3203.228% |
Lukas Biomedical Inc. | 231.83 Million TWD | 82.788% |
RBC Bioscience Corporation | 172.46 Million TWD | 76.863% |
BiOptic Inc. | 228.26 Million TWD | 82.519% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -44236.667% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -318.973% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -722.742% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 97.828% |
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -5381.181% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -97.579% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 89.927% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -77.497% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 71.735% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -4856.894% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 95.015% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 29.891% |
AP Biosciences Inc | 32.25 Million TWD | -23.719% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 96.553% |
3D Global Biotech Inc. | 20.63 Million TWD | -93.394% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 87.312% |
Intech Biopharm Corporation | 25.84 Million TWD | -54.382% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 54.02% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 94.738% |
TCI GENE Inc. | 333.85 Million TWD | 88.048% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -221583.333% |
Senhwa Biosciences, Inc. | 1 Million TWD | -3890.3% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 53.313% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 75.083% |
PharmaEngine, Inc. | 767.66 Million TWD | 94.802% |
Savior Lifetec Corporation | 1.05 Billion TWD | 96.201% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 67.594% |
OBI Pharma, Inc. | 41.54 Million TWD | 3.962% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 82.972% |
Acepodia, Inc. | 16.59 Million TWD | -140.481% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -2.494% |